
ClearPoint Neuro CLPT
€ 9.53
8.12%
Geschäftsbericht 2025
hinzugefügt 17.03.2026
ClearPoint Neuro DSO 2011-2026 | CLPT
DSO Jährlich ClearPoint Neuro
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 55.6 | 46.1 | 44.8 | 44.4 | 47.2 | 53.5 | 35.5 | 61.2 | 47 | 55 | 96.8 | 1.4 K | 3.43 K | 32.1 | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 3.43 K | 32.1 | 389 |
DSO Vierteljährlich ClearPoint Neuro
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 42.5 | 39.2 | 45 | - | 41.3 | 34.8 | 34.2 | - | 41.4 | 42 | 44.9 | - | 59.9 | 49.1 | 41.5 | - | 49.5 | 59 | 44 | - | 48.8 | 69.3 | 10.6 | - | 34 | 38.2 | 20.3 | - | 62.3 | 68.4 | 61.4 | - | 50.5 | 43.8 | 41.3 | - | 48.9 | 71.6 | 68.2 | - | 89.2 | 135 | 76.2 | - | 67.6 | 36 | 68.7 | - | 75.8 | 125 | 43.9 | - | 35.9 | 37.5 | 39.4 | - | 31.7 | 50.7 | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 135 | 10.6 | 52.7 |
DSO anderer Aktien in der Medizinische Geräte
| Name | DSO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
AdaptHealth Corp.
AHCO
|
43.8 | $ 13.11 | 0.23 % | $ 1.77 B | ||
|
BIOLASE
BIOL
|
42 | - | -13.19 % | $ 166 K | ||
|
GenMark Diagnostics, Inc.
GNMK
|
44.2 | - | - | $ 1.77 B | ||
|
Allied Healthcare Products
AHPI
|
161 | - | 3.58 % | $ 2.21 M | ||
|
Lianluo Smart Limited
LLIT
|
215 | - | 24.59 % | $ 44.8 M | ||
|
Eargo
EAR
|
70.8 | - | - | $ 10.2 M | ||
|
Apollo Endosurgery
APEN
|
59.5 | - | - | $ 475 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
724 | - | -5.86 % | $ 30.6 M | ||
|
Second Sight Medical Products
EYES
|
49.1 | - | -0.97 % | $ 54.4 M | ||
|
Electromed
ELMD
|
137 | $ 25.71 | 2.43 % | $ 217 M | ||
|
Avinger
AVGR
|
49.4 | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
49.2 | - | - | $ 3.31 B | ||
|
EDAP TMS S.A.
EDAP
|
91.8 | $ 3.32 | 0.3 % | $ 124 M | ||
|
Aziyo Biologics
AZYO
|
59.5 | - | 1.37 % | $ 20.5 M | ||
|
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | ||
|
Conformis
CFMS
|
55.4 | - | - | $ 16.4 M | ||
|
Helius Medical Technologies
HSDT
|
53.3 | $ 2.04 | 3.03 % | $ 1.24 M | ||
|
Cardiovascular Systems
CSII
|
61.6 | - | 0.15 % | $ 844 M | ||
|
Cytosorbents Corporation
CTSO
|
73.2 | $ 0.61 | -4.04 % | $ 38 M | ||
|
CryoLife, Inc.
CRY
|
70.3 | - | -4.14 % | $ 702 M | ||
|
Inspire Medical Systems
INSP
|
42.6 | $ 56.14 | 5.11 % | $ 1.65 B | ||
|
CHF Solutions, Inc.
CHFS
|
52.9 | - | 1.15 % | $ 34.5 M | ||
|
Invacare Corporation
IVC
|
206 | - | - | $ 24.7 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
62.7 | - | -1.98 % | $ 98.3 M | ||
|
IRIDEX Corporation
IRIX
|
47.5 | $ 1.03 | - | $ 17.4 M | ||
|
Itamar Medical Ltd.
ITMR
|
85.4 | - | 0.03 % | $ 1.58 B | ||
|
Dynatronics Corporation
DYNT
|
41.6 | - | 14.99 % | $ 929 K | ||
|
Misonix, Inc.
MSON
|
64.6 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
120 | - | - | $ 111 M | ||
|
LivaNova PLC
LIVN
|
53.8 | $ 60.1 | 2.0 % | $ 3.28 B | ||
|
OrthoPediatrics Corp.
KIDS
|
74.3 | $ 15.06 | 2.87 % | $ 353 M | ||
|
Butterfly Network
BFLY
|
76.1 | $ 4.79 | -2.64 % | $ 1.01 B | ||
|
Intersect ENT, Inc.
XENT
|
66.1 | - | - | $ 955 M | ||
|
GBS
GBS
|
61.2 | - | -0.57 % | $ 7.12 M | ||
|
Globus Medical
GMED
|
76.8 | $ 90.18 | 2.72 % | $ 12.2 B | ||
|
Delcath Systems
DCTH
|
48.5 | $ 10.38 | 1.67 % | $ 372 M | ||
|
NanoVibronix
NAOV
|
27.7 | - | - | $ 1.08 M | ||
|
CONMED Corporation
CNMD
|
64.5 | $ 36.66 | 1.95 % | $ 1.14 B | ||
|
Integer Holdings Corporation
ITGR
|
58.2 | $ 88.51 | 5.78 % | $ 3.07 B | ||
|
Edwards Lifesciences Corporation
EW
|
38.2 | $ 83.5 | 2.81 % | $ 48.8 B | ||
|
LENSAR
LNSR
|
38.9 | $ 5.23 | -2.97 % | $ 62.5 M | ||
|
Pulmonx Corporation
LUNG
|
50.8 | $ 1.28 | 6.67 % | $ 52.1 M | ||
|
MiMedx Group
MDXG
|
57.3 | $ 3.36 | 8.91 % | $ 497 M | ||
|
Myomo
MYO
|
35.3 | $ 0.86 | 8.54 % | $ 36 M | ||
|
Cutera
CUTR
|
327 | - | -10.19 % | $ 1.99 M | ||
|
NuVasive
NUVA
|
70.4 | - | - | $ 2.07 B | ||
|
Nevro Corp.
NVRO
|
67.6 | - | - | $ 217 M | ||
|
Natus Medical Incorporated
NTUS
|
79 | - | 1.94 % | $ 1.05 B |